Trending...
- BREAKING CONSUMER ALERT: Carvana's "Certified" Luxury SUV Buyer Exposes Legal & Mechanical Trauma 'Presses' Charges of Duress, Deception, and Delay
- Injured While Using Rideshare?
- Mental Health Watchdog Calls Baker Acting of Children in Florida a Parental Rights Violation
SACRAMENTO, Calif. - nvtip -- The ROS1ders, a global group of patients and caregivers living with ROS1+ cancer, announced the recipients of the 2024 ROS1+ Cancer Innovation Award. Funds for the awards were raised through individual contributions to The ROS1ders by patients and supporters. Each award carries a one-year, $75,000 seed grant to fund high-risk, high-reward research projects in ROS1+ cancer.
The recipients of the 2024 ROS1+ Cancer Innovation Awards are:
More on nvtip.com
About The ROS1ders
The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 2000 people from over 50 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaborations with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
About ROS1+ Cancer
More on nvtip.com
The recipients of the 2024 ROS1+ Cancer Innovation Awards are:
- Monte Winslow, PhD, Dmitri A. Petrov, PhD and Joel Neal, MD, PhD, Stanford University School of Medicine – Towards precision medicine for oncogenic ROS1 fusion driven lung cancer
This project will create models of each known ROS1 fusion variant and investigate how they influence cancer development and treatment responses. - Jaime Schneider, MD, PhD, Massachusetts General Hospital – Identifying Metabolic Vulnerabilities in ROS1+ Lung Cancer
This project aims to shed light on metabolic pathways that may contribute to acquired resistance to treatments for ROS1+ cancer, with the goal of identifying new targets for treatments that may prevent or treat resistance mechanisms.
More on nvtip.com
- DivX Enhances AVI Playback Resources; Simplifies Guide to Playing AVI Files with DivX Software
- Patrick Aloni Joins Historic Gold and Copper Discovery in Argentina with Multimillion-Dollar Stake
- Edtech Startup Young Commanders Launches 'Visionaries Without Sight' Collection Celebrating Blind and Visually Impaired Historical Figures
- Info-Tech LIVE 2025 Day 2 Highlights: Bold Strategies for AI, IT Leadership, and Digital Disruption
- Goldstar Rehabilitation Celebrates 15 Years of Early Intervention Across Southeastern PA
About The ROS1ders
The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 2000 people from over 50 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaborations with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
About ROS1+ Cancer
- ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer. The incidence is thought to be similar in other types of cancer.
- Biomarker testing for ROS1 fusions is recommended in guidelines for non-small cell lung cancer, but few other cancers, yet.
- Patients typically have adenocarcinoma NSCLC, a younger age than the average NSCLC patient, and no smoking history (a smoking history should not exclude patients from biomarker testing or targeted therapies).
- Oral targeted therapies are the recommended first-line treatment for metastatic ROS1+ NSCLC and have increased the survival of patients by years. However, these drugs eventually stop working due to acquired resistance. The mechanisms of resistance are not well understood.
More on nvtip.com
- United States Congressional Candidate Peter Coe Verbica Unveils 25-Point Federal Plan to Help Make California Affordable Again
- D8Averse Launches D8Acapture: Disruptive Mobile-First App Transforms Utility Pole Data Collection
- Experience Trembling Firsthand with the New AgeMan® Tremor Simulator
- Wise Business Plans Leads the Way in Investor-Ready Business Plans and Pitch Decks for Startups
- Mauro Schnaidman named as Managing Director in Miami, Florida
Source: The ROS1ders, Inc.
Filed Under: Health
0 Comments
Latest on nvtip.com
- Braxus Entertainment Group Acquires All Star Events
- Global Expansion Fueled via Agreement to Take 90% Ownership of Nook Holdings UAE-Based Sports Incubator by Online Lottery & Sports Game Provider
- Remember Internet Pioneers NetCom Solutions & Network Solutions? Founder Emmit J. McHenry is Now Leading the Emerging Cybersecurity Firm Cycurion
- Celebrating Father's Day Weekend with Free Admission for the entire Family, AKC Dog Show, Best in Show and Puppy Event, Product Vendors
- LIB Continuous Innovation: Custom Rain Test Chambers & IP Labs
- Rasa Introduces Multimodal Voice AI Built for Enterprise at Customer Contact Week Las Vegas
- csky.ai & DuoKey Launch Secure AI Transcription Solution for Microsoft 365
- Reddy launches the #1 simulation training platform at CCW Las Vegas
- PlayClay.io Launches Streamlined Quoting Platform for Manufacturers' Reps and Distributors
- Info-Tech Research Group Launches IT Playbooks Research Center to Solve IT Performance Gaps
- Let's Talk Series: At the Crossroads: Immigration Today
- 365 Connect Ignites The Future of PropTech with Autonomous Marketing and Leasing Platform Launch at Apartmentalize in Las Vegas
- Cyta Cyprus Selects Axiros' AXESS Platform for Cloud-Native, Data-Driven Device Management
- BOXABL Announces Intent to Merge with a SPAC, Targeting Nasdaq Listing
- DealMagik Successfully Concludes National Floral Design Contest with Over 150 Submissions
- Westgate Las Vegas Resort & Casino Unveils The Imperial Sky Villa: A Legendary Tribute to Elvis Presley's Legacy
- Behavioral Health Advocates to Hold Joint Capitol Hill Press Conference on June 11
- VNBTC Becomes The Top Crypto Investment Platform As Its Bitcoin Cloud Mining Solution Goes Viral
- Zentra Completes Integration with Schlage® XE360™ Series
- Advanced Solar Space Technology; Record Efficiency of 15.7%; Agreement to Provide NOVI Space with Rollable PV Array Blankets for Space Launch in 2026